<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A method for large-scale production of a pasteurized antithrombin III (AT III) concentrate for therapeutic use has been adapted from published methods </plain></SENT>
<SENT sid="1" pm="."><plain>It includes the following steps: (1) batchwise adsorption onto <z:chebi fb="5" ids="28304">heparin</z:chebi>-<z:chebi fb="0" ids="2511">Sepharose</z:chebi> from plasma depleted of cryoprecipitate and prothrombin complex; (2) chromatographic elution at high salt concentration; (3) pasteurization for 10 h at 60 degrees C in the presence of added <z:chebi fb="2" ids="50744">citrate</z:chebi> ion; (4) desalting on Sephadex G-25, and (5) <z:mp ids='MP_0001924'>sterile</z:mp> filtration and freeze-drying </plain></SENT>
<SENT sid="2" pm="."><plain>Seven batches prepared in this manner gave a mean yield of 269 U AT III/kg plasma </plain></SENT>
<SENT sid="3" pm="."><plain>The product passed <z:hpo ids='HP_0000001'>all</z:hpo> the usual animal safety and pyrogenicity tests and has been used successfully in several courses of treatment of congenital deficiencies </plain></SENT>
</text></document>